Best treatment for ameloblastoma with lower risk of tumor recurrence: Recurrencia y tratamiento del ameloblastoma

• Autor(a) principal: Araújo de Souza , Arthur
• Data de Publicação: 2023
• Outros Autores: Borba Albuquerque , Geovana, Lyra Neto , João Bezerra, Dias, Vytoria Patrícia Calheiros Silva, de Lyra, Zélia Maria Sarmento de Andrade Lima Fischer, Silva, Luciano Barreto
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/357
• topic: Ameloblastoma; recidiva; Ameloblastoma; recurrence; surgical treatment; Ameloblastoma; Recurrencia

Ameloblastoma accounts for 10% of living tumors of odontogenic origin. Ameloblastoma has an epithelial origin, more commonly occurring in the jaw bone. As much as it is a benign tumor, ameloblastoma tends to be invasive and aggressive, making total tumor resection with a safe margin, with the aim of to prevent future recurrences. This tumor has its own clinical and radiographic aspects, being able to be found in its primordial stage of expansion . The ameloblastoma lesion maintains several alterations in its clinical signs, which may manifest periods of tumor aggressiveness. Its cause is uncertain, so it appears in a variety of ways.